Style | Citing Format |
---|---|
MLA | Hassanzadeh M, et al.. "Design, Synthesis, and Bio-Evaluation of New Isoindoline-1,3-Dione Derivatives As Possible Inhibitors of Acetylcholinesterase." Research in Pharmaceutical Sciences, vol. 16, no. 5, 2021, pp. 482-492. |
APA | Hassanzadeh M, Hassanzadeh F, Khodarahmi GA, Rostami M, Azimi F, Nadri H, Homayouni Moghadam F (2021). Design, Synthesis, and Bio-Evaluation of New Isoindoline-1,3-Dione Derivatives As Possible Inhibitors of Acetylcholinesterase. Research in Pharmaceutical Sciences, 16(5), 482-492. |
Chicago | Hassanzadeh M, Hassanzadeh F, Khodarahmi GA, Rostami M, Azimi F, Nadri H, Homayouni Moghadam F. "Design, Synthesis, and Bio-Evaluation of New Isoindoline-1,3-Dione Derivatives As Possible Inhibitors of Acetylcholinesterase." Research in Pharmaceutical Sciences 16, no. 5 (2021): 482-492. |
Harvard | Hassanzadeh M et al. (2021) 'Design, Synthesis, and Bio-Evaluation of New Isoindoline-1,3-Dione Derivatives As Possible Inhibitors of Acetylcholinesterase', Research in Pharmaceutical Sciences, 16(5), pp. 482-492. |
Vancouver | Hassanzadeh M, Hassanzadeh F, Khodarahmi GA, Rostami M, Azimi F, Nadri H, et al.. Design, Synthesis, and Bio-Evaluation of New Isoindoline-1,3-Dione Derivatives As Possible Inhibitors of Acetylcholinesterase. Research in Pharmaceutical Sciences. 2021;16(5):482-492. |
BibTex | @article{ author = {Hassanzadeh M and Hassanzadeh F and Khodarahmi GA and Rostami M and Azimi F and Nadri H and Homayouni Moghadam F}, title = {Design, Synthesis, and Bio-Evaluation of New Isoindoline-1,3-Dione Derivatives As Possible Inhibitors of Acetylcholinesterase}, journal = {Research in Pharmaceutical Sciences}, volume = {16}, number = {5}, pages = {482-492}, year = {2021} } |
RIS | TY - JOUR AU - Hassanzadeh M AU - Hassanzadeh F AU - Khodarahmi GA AU - Rostami M AU - Azimi F AU - Nadri H AU - Homayouni Moghadam F TI - Design, Synthesis, and Bio-Evaluation of New Isoindoline-1,3-Dione Derivatives As Possible Inhibitors of Acetylcholinesterase JO - Research in Pharmaceutical Sciences VL - 16 IS - 5 SP - 482 EP - 492 PY - 2021 ER - |